Scientific guidelines with SmPC recommendations
Scientific guidelines with SmPC recommendations EMA/813125/2012 Page 2/5 Guidelines Reference to specific SmPC section(s) treatment of HIV infection
Download Scientific guidelines with SmPC recommendations
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
Immune Globulin (IG) Therapy Medication and/or …
www.aetna.comImmune Globulin (IG) Therapy Medication Aetna Precertification Notification 503 Sunport Lane, Orlando, FL 32809 and/or Infusion Precertification Request
Aetna, Immune, Globulin, Precertification, Immune globulin, Aetna precertification
For many patients, IVIG is the transmissible …
www.apsfa.orgA simple blood test done before the infusion will determine if you do not have IgA. When IVIG is flowing into a vein, it puts a moderately severe strain on the heart, lungs and
Coagulation in pregnancy - CSEN
www.csen.com7 Coagulation in pregnancy Patrick Thornton, BMSc, MBBCh, FCARCSI, Clinical Research Fellow, Joanne Douglas, MD, FRCPC, Clinical Professor* Department of Anesthesia, University of British Columbia, BC Women’s Hospital, …
The PATH study - CIDP Treatment With …
www.gbs-cidp.org1 Hizentra CIDP (PATH) – IgPro20_3003 K. Goodwin 21 Nov. 2012 The PATH study - CIDP Treatment With Subcutaneous Immunoglobulin (IgPro20) CSL Behring is currently recruiting patients for the PATH study, an international clinical
With, Treatment, Subcutaneous, Immunoglobulin, Ipdc, Cidp treatment with subcutaneous immunoglobulin, Igpro20
Intravenous Immunoglobulin (IVIG) Why am I …
www.mgawpa.orgIntravenous Immunoglobulin (IVIG) Common questions patients ask about IVIG therapy for Myasthenia Gravis Why am I being, or might be treated with IVIG?
Intravenous, Immunoglobulin, Intravenous immunoglobulin, Ivig
Myasthenia Gravis: Clinical Guidelines
www.myastheniagravis.cz3 Cholinesterase inhibitors and immunosuppressive treatment are effective in most cases and the response to plasma exchange and IVIg is often remarkable.
1. Stevens-Johnson Syndrome and Toxic Epidermal …
www.sjsupport.orgTreatment of Severe Drug Reactions 1. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Definition SJS and TEN are variants of the same process, presenting as severe mucosal erosions
Syndrome, Johnson, Toxic, Johnson syndrome and toxic epidermal, Epidermal, Johnson syndrome and toxic epidermal necrolysis, Necrolysis
Related search queries
Immune Globulin, Aetna Precertification, Precertification, Patients, IVIG is the transmissible, IVIg, Coagulation in pregnancy, CIDP Treatment With Subcutaneous Immunoglobulin IgPro20, Intravenous Immunoglobulin IVIG, Myasthenia Gravis, Johnson Syndrome and Toxic Epidermal, Johnson Syndrome and Toxic Epidermal Necrolysis